ici 118551 has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bihari, D; Crossley, I; Gimson, A; Harry, J; Westaby, D; Williams, R | 1 |
| Baxter, JN; Devitt, P; Jenkins, SA; Johnston, JN; Shields, R | 1 |
2 other study(ies) available for ici 118551 and Liver Cirrhosis
| Article | Year |
|---|---|
Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Hypertension, Portal; Indocyanine Green; Liver Cirrhosis; Male; Middle Aged; Portal System; Propanolamines | 1984 |
Effects of a selective beta 2-blocker (ICI 118,551) on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Heart Rate; Hemodynamics; Liver; Liver Cirrhosis; Male; Portal Vein; Propanolamines; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance | 1985 |